Therefore, the PKG system could be another tool to help clinicians identify patients who may benefit from optimization of current treatments or addition of new “ON-extenders,” and for monitoring responsiveness to treatment after regimens are modified, including possible dyskinesia. Here, PRKG1 is linked to Dyskinesia.